Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4174183
Max Phase: Preclinical
Molecular Formula: C58H98N12O13
Molecular Weight: 1171.49
Molecule Type: Small molecule
Associated Items:
ID: ALA4174183
Max Phase: Preclinical
Molecular Formula: C58H98N12O13
Molecular Weight: 1171.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C58H98N12O13/c1-14-34(10)47(57(82)69-48(36(12)71)58(83)70-25-17-19-45(70)56(81)67-46(33(8)9)49(60)74)68-55(80)43(28-32(6)7)65-54(79)44(29-38-20-22-39(73)23-21-38)66-51(76)40(18-15-16-24-59)63-53(78)42(27-31(4)5)64-50(75)35(11)61-52(77)41(26-30(2)3)62-37(13)72/h20-23,30-36,40-48,71,73H,14-19,24-29,59H2,1-13H3,(H2,60,74)(H,61,77)(H,62,72)(H,63,78)(H,64,75)(H,65,79)(H,66,76)(H,67,81)(H,68,80)(H,69,82)/t34-,35-,36+,40-,41-,42-,43-,44-,45-,46-,47-,48-/m0/s1
Standard InChI Key: NTXDPDHLRNNJCJ-QWMKDVIXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1171.49 | Molecular Weight (Monoisotopic): 1170.7376 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):